Home > Income Statement > WINDLAS BIOTECH

WINDLAS BIOTECH
Revenue

    Back to Income Statement
WINDLAS BIOTECH is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for WINDLAS BIOTECH
Please provide your vote to see the results

WINDLAS BIOTECH Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹631 Cr₹513 Cr₹466 Cr₹428 Cr₹329 Cr

What is the latest Revenue of WINDLAS BIOTECH ?

The latest Revenue ratio of WINDLAS BIOTECH is ₹631 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹631 Cr
Mar2023₹513 Cr
Mar2022₹466 Cr
Mar2021₹428 Cr
Mar2020₹329 Cr

How is Revenue of WINDLAS BIOTECH Trending?

Years Revenue % Change
Mar2024 ₹631 Cr
22.97
Mar2023 ₹513 Cr
10.12
Mar2022 ₹466 Cr
8.96
Mar2021 ₹428 Cr
30.03
Mar2020 ₹329 Cr -

Compare Revenue of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,874.3 Cr -12.4% -3.5% 67% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹396,394.0 Cr -6.7% 2.6% 5% Stock Analytics
DIVIS LABORATORIES ₹142,920.0 Cr -6.6% -3.7% 43.8% Stock Analytics
CIPLA ₹114,383.0 Cr -5.3% -2.9% -1.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹105,817.0 Cr -3.8% 1.8% 25.8% Stock Analytics
DR REDDYS LABORATORIES ₹91,385.4 Cr -4.9% -3.3% -10.2% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

-12.4%

-3.5%

67%

SENSEX

-3.6%

-0.7%

-0.5%


You may also like the below Video Courses